In neurons, mtROS might be induced by Aβ-binding alcohol dehydrogenase (ABAD) [16,17]; therefore, targeting the Aβ-ABAD interaction has emerged as a novel therapeutic strategy for AD [18]. The gene discussed is HSD17B10; the disease is Alzheimer disease.